384 related articles for article (PubMed ID: 10761449)
1. Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients.
Wu H; Wasik MA; Przybylski G; Finan J; Haynes B; Moore H; Leonard DG; Montone KT; Naji A; Nowell PC; Kamoun M; Tomaszewski JE; Salhany KE
Am J Clin Pathol; 2000 Apr; 113(4):487-96. PubMed ID: 10761449
[TBL] [Abstract][Full Text] [Related]
2. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature.
Khan WA; Yu L; Eisenbrey AB; Crisan D; al Saadi A; Davis BH; Hankin RC; Mattson JC
Am J Clin Pathol; 2001 Jul; 116(1):41-50. PubMed ID: 11447750
[TBL] [Abstract][Full Text] [Related]
3. Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.
Hassan R; Franco SA; Stefanoff CG; Romano SO; Diamond HR; Franco LG; Seuánez HN; Zalcberg IR
Pathol Int; 2006 Nov; 56(11):668-73. PubMed ID: 17040289
[TBL] [Abstract][Full Text] [Related]
4. Hepatosplenic gamma delta T-cell lymphoma associated with hepatitis B virus infection.
Ozaki S; Ogasahara K; Kosaka M; Inoshita T; Wakatsuki S; Uehara H; Matsumoto T
J Med Invest; 1998 Feb; 44(3-4):215-7. PubMed ID: 9597812
[TBL] [Abstract][Full Text] [Related]
5. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.
Vega F; Medeiros LJ; Bueso-Ramos C; Jones D; Lai R; Luthra R; Abruzzo LV
Am J Clin Pathol; 2001 Sep; 116(3):410-9. PubMed ID: 11554170
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
7. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type.
Wong KF; Chan JK; Matutes E; McCarthy K; Ng CS; Chan CH; Ma SK
Am J Surg Pathol; 1995 Jun; 19(6):718-26. PubMed ID: 7755158
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
[TBL] [Abstract][Full Text] [Related]
9. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.
Ohshima K; Haraoka S; Harada N; Kamimura T; Suzumiya J; Kanda M; Kawasaki C; Sugihara M; Kikuchi M
Histopathology; 2000 Feb; 36(2):127-35. PubMed ID: 10672057
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two cases.
Kagami Y; Sobue R; Ito N; Yatabe Y; Taji H; Suzuki R; Seto M; Ogura M; Suchi T; Morishima Y; Nakamura S
Int J Hematol; 1999 Aug; 70(2):105-11. PubMed ID: 10497849
[TBL] [Abstract][Full Text] [Related]
11. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
[TBL] [Abstract][Full Text] [Related]
12. Gamma/delta T-cell lymphoma with hepatosplenomegaly: report of a case.
Ohno T; Komada F; Yamaguchi M; Oka K; Nishii K; Tsuda M; Katsuta K; Yamaguchi T; Kita K; Shirakawa S
Int J Hematol; 1993 Jun; 57(3):269-76. PubMed ID: 8364190
[TBL] [Abstract][Full Text] [Related]
13. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.
Cooke CB; Krenacs L; Stetler-Stevenson M; Greiner TC; Raffeld M; Kingma DW; Abruzzo L; Frantz C; Kaviani M; Jaffe ES
Blood; 1996 Dec; 88(11):4265-74. PubMed ID: 8943863
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin.
Kremer M; Sandherr M; Geist B; Cabras AD; Höfler H; Fend F
Mod Pathol; 2001 Feb; 14(2):91-7. PubMed ID: 11235910
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.
Weidmann E; Hinz T; Klein S; Schui DK; Harder S; Kriener S; Kabelitz D; Hoelzer D; Mitrou PS
Haematologica; 2000 Oct; 85(10):1024-31. PubMed ID: 11025592
[TBL] [Abstract][Full Text] [Related]
16. Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature.
Niitsu N; Kohri M; Togano T; Nakamine H; Nakamura S; Iwabuchi K; Higashihara M
Eur J Haematol; 2004 Nov; 73(5):367-71. PubMed ID: 15458516
[TBL] [Abstract][Full Text] [Related]
17. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection.
Zhang WY; Li GD; Liu WP; Ouyang Q; Ren XC; Li FY; Xu H
Chin Med J (Engl); 2005 Sep; 118(18):1542-8. PubMed ID: 16232331
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.
Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M
Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388
[TBL] [Abstract][Full Text] [Related]
19. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.
Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M
Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001
[TBL] [Abstract][Full Text] [Related]
20. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.
Przybylski GK; Wu H; Macon WR; Finan J; Leonard DG; Felgar RE; DiGiuseppe JA; Nowell PC; Swerdlow SH; Kadin ME; Wasik MA; Salhany KE
J Mol Diagn; 2000 Feb; 2(1):11-9. PubMed ID: 11272897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
